This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that
class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Herbalife Ltd. (“Herbalife” or the “Company”) (NYSE: HLF) between May 4, 2010 and April 11, 2014, inclusive (the “Class Period”).
If you purchased or otherwise acquired Herbalife securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than June 13, 2014. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the action will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
Herbalife investors who wish to learn more about the action and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.
Background on the Herbalife Securities Class Litigation
Herbalife, headquartered in Los Angeles, California, is a multilevel network marketing company that sells weight management, nutritional supplement and personal care products.
The action alleges that throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose material facts regarding Herbalife’s business, operational and compliance policies, specifically that: (i) Herbalife’s operations were based on a pyramid scheme whereby its distributors generated revenue by recruiting other distributors, rather than by selling Herbalife’s diet and nutritional products to the general public; (ii) the Company engaged in deceptive trade practices where it unduly pressured its members to purchase more products to resell as one of its “distributors”; and (iii) as a result of the above, the Company’s financial statements were materially false and misleading at all relevant times.